Experience
Forward Pharma IP APS
Biogen MA, Inc.
Represented Biogen MA, Inc. in an interference proceeding before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) and obtained a favorable ruling for a patent covering Tecfidera®.
Forward Pharma IP APS v. Biogen MA, Inc., 106,023, PTAB, Judges Gardner-Lane, Katz, Schafer
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
Antares Pharma, Inc. v. Medac Pharma, Inc.
Antares Pharma, Inc.
Siemens Healthcare Diagnostics Inc. v. Radiometer Medical ApS
Radiometer Medical ApS
Universal Electronics, Inc. v. Caavo Inc.
Caavo Inc.
Sequenom, Inc. et al
Biogen MA Inc.
Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc.
Alzheon, Inc.
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Biogen International GmbH
PTAB holds unpatentable in IPR all claims in Clouding's data synchronization patent
Rackspace Hosting, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.